95176 ⎘
Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms; Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Cell differentiation inducer
#302Therapeutic agents useful for treating pain
#303Process for producing optically active β-hydroxy-α-aminocarboxylic acid derivative
#304Process for the preparation of N-monosubstituted beta-amino alcohols
#305Novel Compounds, Their Preparations And Use
#306THIOUREA COMPOUNDS
#307ENTACAPONE-DERIVATIVES
#308THIOUREA COMPOUNDS
#3094-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
#310Methods and compositions for modulating sphingosine -1- phosphate (S1P) receptor activity
#311Compounds for the treatment of metabolic disorders
#312Compounds for the treatment of metabolic disorders
#313Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
#314Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
#315Therapeutic compounds
#316THERAPEUTIC COMPOUNDS
#317COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#318Hydroxamates as therapeutic agents
#319NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS
#320ANTI-INFECTIVE AGENTS AND METHODS OF USE
#321Modulators of peroxisome proliferator activated receptors
#322Compounds, compositions and methods for the treatment of synucleinopathies
#323Naphthalene compounds as selective estrogen receptor modulators
#324COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#325Method for the treatment of metabolic disorders
#326Sulfoxyalkylthiophene and process for producing the same
#327Therapeutic compounds
#328Therapeutic cyclopentane derivatives
#329COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#330COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#331Modulators of Crth-2 Receptor Activity for the Treatment of Prostaglandin D2 Mediated Diseases
#332Substituted and -stilbenes as therapeutic agents
#333Method for the treatment of metabolic disorders
#334COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#335COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
#336Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
#337ω-Cycloalkyl 17-heteroaryl prostaglandin Eanalogs as EP-receptor agonists
#338Method of preparing thieno[3,2-c]pyridine derivatives and intermediates used therein
#339DNT-fumarate and methods of preparation thereof
#340Hydrazide derivatives as prostaglandin receptors modulators
#341π-conjugated aromatic ring-containing compound and organic electroluminescent device
#342Hsp90 family protein inhibitors
#343Biaryl nitrogen-heterocycle inhibitors of LTA4H for treating inflammation
#344Calcium receptor modulating agents
#345Method for producing enantiomer-pure aminoalcohols
#346Methods for the treatment of metabolic disorders such as diabetes
#347Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
#348Methods for the production of 3-methylamino-1-(thiene-2-yl)-propane-1-ol
#349Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders
#3504-SUBSTITUTED 2-ARYLOXYPHENOL DERIVATIVES AS ANTIBACTERIAL AGENTS
#351Cannabinoids
#352Process for the purification of duloxetine hydrochloride
#353Sodium channel modulators
#354Process for the preparation of optically active (S)-(+)-N,N-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine
#355Pure duloxetine hydrochloride
#356Inhibitors of histone deacetylase
#357(S)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof
#3581,3-Bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
#359Process for the asymmetric hydrogenation of beta-amino ketones
#360Phenyl compounds
#361Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#3622-(2 Or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
#363Process for preparing duloxetine and intermediates for use therein
#364Compounds that are useful for improving pharmacokinetics
#365Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
#366Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
#367KCNQ channel modulating compounds and their pharmaceutical use
#3681-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
#369Benzamides as ppar modulators
#370Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity
#3713-methylamino-1-(2-thienyl)-1-propanone, production and use thereof
#372Compounds with activity at estrogen receptors
#373Cathepsin cysteine protease inhibitors
#374Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
#375Catalytic hydrogenation of carbon-heteroatom double bonds
#376Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines
#377Aminodicarboxylic acid derivatives having pharmaceutical properties
#378Thiophene derivative PPAR modulators
#379Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
#380N-protected/N-substituted-beta-amino hydroxy sulfonates
#381Process for preparing 2,5-disubstituted 3-alkylthiophenes
#382Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
#3834-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
#384Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
#385Chiral diols, their manufacture and ligands and catalysts derived therefrom
#386Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
#387Sulphonamide derivatives
#388Long chain aliphatic alcohol derivatives and methods of making and using same
#389Ligands of adenine nucleotide translocase (ANT) and compositions and methods related thereto
#3904-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
#391Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
#392Compounds for the treatment of metabolic disorders
#393Methods of 1,3-enyne preparation using copper (I) catalysts
#394Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#395Process for the preparation of N-alkyl-N-methyl-3-hydroxy-3-(2-thienyl)-propylamines
#396Hydroxamates as therapeutic agents
#397Reactive mesogenic charge transport compounds
#398N-acylaminoacetonitrile derivatives and their use for controlling parasites
#399Cannabinoids
#400Cannabinoids
#401Calcium receptor modulating agents
#402Pesticidal heterocycles
#403Sodium channel modulators
#404Synthesis for the preparation of compounds for screening as potential tubulin binding agents
#4054-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
#406Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials
#4076-Fluorobicyclo[3.1.0]hexane derivatives
#408Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
#4093-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same
#410Calcium receptor antagonists
#411Lily of the valley aromachemicals
#412Compound for the treatment of metabolic disorders
#413Vitamin D derivatives with carbo-or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
#414Diamine derivatives, process for producing the diamine derivatives, and fungicides containing the diamine derivatives as an active ingredient
#415Perfluorinated amide salts and their uses as ionic conducting materials
#416Carbamates of 2-heterocyclic-1,2-ethanediols
#417Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
#4184-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
#419High refractive index, UV-curable monomers and coating compositions prepared therefrom
#420Method of making a high refractive index optical management coating and the coating
#421N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists
#422Modulators of peroxisome proliferator activated receptors
#4231, 5-diaminopentan-3-ol compounds and related treatment methods
#424Immunosuppressant compounds and compositions
#425Prodrugs of excitatory amino acids
#426Compounds for the treatment of metabolic disorders